Molders & Plastics Processors Available for Acquisition

MBS Advisors always has a dynamic portfolio of sell-side mandates and we endeavor to keep the below list of opportunities updated and current. Please review what we have posted and then contact us for additional information.

The MBS network includes many businesses that are in the early stages of exit planning. As a potential acquirer, if you have a specific need or strategic plan, please contact us. We might know a molder or processor in your “sweet spot” that would be willing to talk.

Check back often as these opportunities frequently change. 

Medical Injection Molder in the Northeast – $25 million in sales

Highlights:

  • $25 Million in sales, $5 Million in adjusted EBITDA
  • 100,000 ft2 state-of-the-art facility
  • Nearly 40 injection presses up to 500 tons
  • Capabilities include thermoplastic molding, silicone molding, and assembly
  • Focus is manufacturing small, complex parts and assemblies for medical and life science OEMs
  • Multiple medical clean rooms; ISO 13485 registered

For more information on this business, contact Andrew Munson, 413-584-2095 or click here for a brief summary of this opportunity.

 
 

Automotive Injection Molder in Mexico – $15 million in sales

This acquisition opportunity involves an automotive Tier-2 injection molder in Mexico.

Highlights:

  • 60,000 square feet in upscale industrial park
  • Injection presses to 1750 tons
  • Mexican owned/operated
  • Audited financials
  • Located near a major hub for automotive and appliance manufacturing

For more information on this business, contact Andrew Munson, 413-584-2095.

 
 

Mold Maker in Asia – $15 million in sales

This acquisition opportunity involves a mold maker with production facilities in Asia.

Highlights:

  • $15M in revenue
  • $1.5M EBITDA
  • High precision, complex molds – Reputation for quality
  • Serving various industries, including automotive, medical and electronics
  • Main markets U.S. and Europe
  • Production facilities in Asia with local support in the U.S. and Europe

For more information on this business, contact Edward van de Krol, 413-570-7212.

Custom Injection Molder in South Carolina – $7 million in sales

This acquisition opportunity involves a custom injection molding company in South Carolina.

Highlights:

  • $7M in revenue
  • 22% EBITDA
  • 20,000 square feet
  • 24 molding machines up to 1450 tons
  • Turnkey opportunity

For more information on this business, contact Joel Minnick, 413-584-5620.

Custom Injection Molder in Texas – $6 million in sales

This acquisition opportunity involves a custom injection molding company in Texas.

Highlights:

  • $6M in revenue
  • $300K EBITDA
  • 30,000 square feet with excellent curb appeal
  • Very small parts
  • 15 minutes from a large, international airport
  • Positioned to double in size over the next two years

For more information on this business, contact Edward van de Krol, 413-570-7212 or click here for a brief summary of this opportunity.

Custom Injection Molder in the Midwest – $4 million in sales

This acquisition opportunity involves a custom injection molding company in the Midwest region of the united states.

Highlights:

  • $4M in revenue
  • 44% contribution margin
  • 43,000 square feet
  • Diverse customer base

For more information on this business, contact Jonathan Soucy, 413-406-1011 or click here for a brief one-page summary of this opportunity.

Custom Injection Molder with proprietary product lines – $3 million in sales

This acquisition opportunity involves a custom injection molding company with proprietary product lines in California.

Highlights:

  • $3M in revenue
  • $500k in proprietary product lines
  • 60,000 square feet
  • 25 injection molding presses
  • End markets include commercial, agriculture, aerospace/defense and healthcare
  • Secondary operations include ultrasonic welding, pad printing & assembly

For more information on this business, contact Edward van de Krol, 413-570-7212 or click here for a brief one-page summary of this opportunity.